Potassium Citrate Tablet, Extended Release
Product Images NDC 72162-2121

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 72162-2121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of potassium citrate hydrate showing a central carbon atom bonded to three CH2-COOK groups and one hydroxyl group (OH), associated with a water molecule (H2O).*

FDA Label Image

Table 1. (Table 1.)

A table illustrating the effect of Potassium Citrate on patients with calcium oxalate nephrolithiasis. It displays data on the number of stones formed per year across four patient groups, comparing baseline and on-treatment values, along with remission percentages and rates of any decrease in stone formation.*

FDA Label Image

Label (Lbl721622121)

The image shows a label for Potassium Citrate Extended-Release Tablets, USP, with a strength of 15 mEq (1620 mg) per tablet. The tablets are uncoated, oval-shaped, and off-white to tan yellowish in color. The label indicates the product is relabeled by Bryant Ranch Prepack and manufactured by Ascent Pharmaceuticals. Package contains 100 tablets and includes storage instructions and barcode details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.